Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q3)Aug 31, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | (Q3)Aug 31, 2023 | (Q2)May 31, 2023 | (Q1)Feb 28, 2023 | (FY)Nov 30, 2022 | (Q4)Nov 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 18.02%9.84B | 21.98%8.81B | 13.29%8.33B | 19.35%30.56B | 11.34%7.64B | 27.57%8.34B | 7.22B | 7.36B | 22.40%25.61B | 6.87B |
Cost of revenue | 29.61%6.36B | 28.82%5.74B | 17.10%5.35B | 12.53%18.91B | 2.50%4.97B | 18.87%4.91B | 4.45B | 4.57B | 13.85%16.8B | 4.85B |
Gross profit | 1.45%3.48B | 10.98%3.07B | 7.02%2.98B | 32.36%11.65B | 32.66%2.67B | 42.50%3.43B | 2.77B | 2.78B | 42.88%8.81B | 2.01B |
Operating expense | 11.95%1.73B | 14.76%1.75B | 21.06%1.62B | 22.48%6.1B | 16.63%1.7B | 30.87%1.55B | 1.52B | 1.33B | 12.49%4.98B | 1.45B |
Staff costs | 29.88%477.88M | 21.41%371.09M | 11.73%426.46M | ---- | ---- | 5.35%367.93M | --305.66M | --381.67M | ---- | ---- |
Selling and administrative expenses | --267.18M | 28.45%361.39M | -2.19%320.84M | ---- | ---- | ---- | --281.36M | --328.04M | ---- | ---- |
-Selling and marketing expense | --267.18M | 28.45%361.39M | -2.19%320.84M | ---- | ---- | ---- | --281.36M | --328.04M | ---- | ---- |
Other operating expenses | -44.87%985.13M | 8.48%1.02B | 38.95%868.59M | ---- | ---- | 22.23%1.79B | --935.73M | --625.1M | ---- | ---- |
Operating profit | -7.16%1.75B | 6.34%1.32B | -5.91%1.36B | 45.22%5.55B | 74.40%974.68M | 53.69%1.89B | 1.25B | 1.45B | 120.43%3.82B | 558.89M |
Net non-operating interest income (expenses) | 68.44%-190K | -17.66%-786K | 2.28%-601K | 89.18%-2.54M | 96.30%-658K | 64.25%-602K | -668K | -615K | -188.76%-23.5M | -17.77M |
Non-operating interest income | 1,379.55%651K | --0 | 33.33%52K | 159.38%83K | --0 | 144.44%44K | --0 | --39K | 10.34%32K | --0 |
Non-operating interest expense | 30.19%841K | 17.66%786K | -0.15%653K | -62.89%2.63M | -49.73%658K | -62.04%646K | --668K | --654K | -13.36%7.08M | --1.31M |
Total other finance cost | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --16.46M | ---- |
Net investment income | ||||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | -28.00%-18.36M | 72.04%-1.55M | 0 | -146.90%-14.34M | -5.53M | |||||
Less:Other special charges | ---- | ---- | ---- | 28.00%18.36M | -72.04%1.55M | --0 | ---- | ---- | 146.90%14.34M | --5.53M |
Other non-operating income (expenses) | 73.39%47.56M | -47.62%32.94M | -16.43%32.01M | 181.59%74.71M | -860.74%-53.92M | 442.93%27.43M | 62.9M | 38.3M | -53.28%26.53M | 7.09M |
Income before tax | -0.55%1.9B | 5.10%1.36B | -6.18%1.39B | 47.06%5.61B | 69.26%918.56M | 55.75%1.91B | 1.29B | 1.49B | 110.18%3.81B | 542.68M |
Income tax | 35.86%626.55M | -10.71%443.84M | -20.20%455.78M | 14.36%1.65B | -9.61%125.04M | 4.03%461.17M | 497.09M | 571.16M | 145.34%1.45B | 138.34M |
Net income | -12.12%1.28B | 14.99%913.17M | 2.57%938.5M | 67.05%3.95B | 96.25%793.52M | 84.97%1.45B | 794.13M | 914.98M | 93.25%2.37B | 404.35M |
Net income continuous operations | -12.12%1.28B | 14.99%913.17M | 2.57%938.5M | 67.05%3.95B | 96.25%793.52M | 84.97%1.45B | --794.13M | --914.98M | 93.25%2.37B | --404.35M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | -12.12%1.28B | 14.99%913.17M | 2.57%938.5M | 67.05%3.95B | 96.25%793.52M | 84.97%1.45B | 794.13M | 914.98M | 93.25%2.37B | 404.35M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -12.12%1.28B | 14.99%913.17M | 2.57%938.5M | 67.05%3.95B | 96.25%793.52M | 84.97%1.45B | 794.13M | 914.98M | 93.25%2.37B | 404.35M |
Gross dividend payment | ||||||||||
Basic earnings per share | -12.01%55.51 | 14.62%39.58 | 1.94%40.55 | 49.30%171.74 | 103.11%34.34 | 84.96%63.09 | 34.53 | 39.78 | 87.85%115.03 | 16.9069 |
Diluted earnings per share | -10.76%53.22 | 16.07%37.91 | 3.11%38.85 | 51.55%164.36 | 103.11%34.34 | 74.85%59.64 | 32.66 | 37.68 | 77.10%108.45 | 16.9069 |
Dividend per share | 0 | 45 | 0 | 75 | 75 | |||||
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |